The QMN Weekly Bulletin
Quality / Medical Devices / Regulatory Affairs / Inspections and Audits

St. Jude Makes Progress on Warning, Sees CRM Growth in Fourth Quarter

March 7, 2014
A A
St. Jude’s Sylmar, Calif., plant, which makes most of its CRM products, should soon emerge from an FDA warning letter, CEO Dan Starks said on the company’s earnings call last month.
The GMP Letter